Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Causality in Epidemiology01:21

Causality in Epidemiology

Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Probability Laws01:49

Probability Laws

Overview

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collision Tumor of Metastatic Lung Adenocarcinoma to Lower Limb Leiomyosarcoma: Case Report and Literature Review.

International journal of surgical pathology·2026
Same author

MOVIN in ICU: An observational study of Mobilisation On Vasopressors and INotropes in intensive care.

Heart & lung : the journal of critical care·2026
Same author

Quantitative bias analysis for unmeasured confounding in unanchored population-adjusted indirect comparisons.

Research synthesis methods·2026
Same author

Letter in response to Salari M, et al. Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis.

Journal of Huntington's disease·2026
Same author

Observed total and live birth prevalence of Wolf-Hirschhorn syndrome in England 2015-2020.

Clinical dysmorphology·2025
Same author

Variation in the reported prevalence of Huntington's disease: a systematic review and guide to interpretation.

Journal of neurology·2025
Same journal

Flexible Survival Extrapolation with Blended Hazards: Accounting for Treatment Effect Waning in Health Technology Assessment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Microsimulation Model for Chronic Kidney Disease Progression in Type 2 Diabetes Patients in the United States: Michigan Model for Diabetes-Chronic Kidney Disease Model.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Cardiovascular Risk Estimation and Statin Adherence: A Historical Cohort Study.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Taste or Scale? Methodological Approach to Health Preferences Comparison across Groups.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

Mind the Gap: Impact of New Labels on Public Perceptions and Calculated Risk of Adverse Outcomes after a Melanoma In Situ Diagnosis-A Secondary Analysis of an Online Randomized Experiment.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
Same journal

A Metamodel-Based General-Purpose Autocalibration Tool for Simulation Models.

Medical decision making : an international journal of the Society for Medical Decision Making·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

Bayesian inference for comorbid disease risks using marginal disease risks and correlation information from a

Mark Strong1, Jeremy E Oakley2

  • 1School of Health and Related Research (MS)

Medical Decision Making : an International Journal of the Society for Medical Decision Making
|January 8, 2011
PubMed
Summary
This summary is machine-generated.

Public health interventions require accurate cost-effectiveness analysis. Ignoring disease comorbidity leads to overestimating benefits, particularly when interventions affect disease correlations.

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Related Experiment Videos

Last Updated: Jun 5, 2026

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

Area of Science:

  • Health Economics
  • Epidemiology
  • Biostatistics

Background:

  • Public health interventions target upstream determinants of health.
  • Interventions often reduce incidence of multiple, correlated diseases (comorbidity).
  • Accurate estimation of comorbid disease risks is challenging with single disease data.

Purpose of the Study:

  • To develop a method for estimating comorbid disease risks.
  • To evaluate the cost-effectiveness of public health interventions considering comorbidity.
  • To quantify the impact of comorbidity on intervention benefit estimation.

Main Methods:

  • Employed a Bayesian multivariate probit model to estimate disease correlations.
  • Integrated disease-specific risks and intervention effects for comorbid risk calculation.
  • Utilized a physical activity cost-effectiveness model case study.

Main Results:

  • Ignoring comorbidity leads to overestimation of incremental benefits.
  • Overestimation is most pronounced when interventions impact disease co-occurrence and risk.
  • Sensitivity analysis explored the impact of varying disease risk correlations.

Conclusions:

  • The proposed method corrects for overestimation of intervention benefits.
  • This approach enables sensitivity analysis regarding disease risk correlations.
  • Accurate comorbidity assessment is crucial for reliable public health intervention evaluation.